Annual Drug Patent Expirations for TYZEKA
Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug.
This drug has fifty-five patent family members in twenty-one countries.
The generic ingredient in TYZEKA is telbivudine. Additional details are available on the telbivudine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
